Insurance appeal letter generator
Personalized appeal letter for Wegovy, Zepbound, Ozempic, or Mounjaro coverage denial
Plan claims the medication isn't medically necessary for your condition.
How to use this letter
- Fill in the fields above with your information and the exact denial reason cited in your insurance letter.
- Click Generate appeal letter.
- Review the draft — it's a starting point, not the final letter.
- Have your prescriber review and add their clinical reasoning. Most successful appeals have a separate letter from the prescriber attached.
- Attach the original denial letter, prescriber's letter of medical necessity, and any relevant medical records (BMI history, comorbidity documentation).
- Submit per your insurance plan's appeal instructions. Most plans accept email/portal upload; some require fax or certified mail.
- Track timing. Non-urgent appeals typically must be decided within 30 calendar days (varies by state and plan type).
- If denied at first level, escalate to second-level appeal, then to external review if available.
What makes appeals succeed
- Specific clinical documentation. A letter that says “BMI 33.2, type 2 diabetes A1C 7.8, hypertension on lisinopril, prior 6 months of structured lifestyle program with 4 lb loss” beats a letter that says “patient is obese and needs treatment.”
- Prescriber engagement. Plans take appeals more seriously when the prescriber is engaged. A peer-to-peer review with the plan's medical reviewer (which your prescriber can request) often reverses denials.
- Citing FDA-approved indications and current guidelines. AACE/Obesity Medicine Association 2024-2025 guidelines explicitly support GLP-1s as first-line for patients meeting criteria.
- Documenting prior failures honestly. Plans look for step-therapy completion. List specific programs, durations, and outcomes.
- Persistence. Many successful appeals took 2-3 rounds. Don't accept the first denial as final.
If your appeal is denied
Most plans offer 2-3 internal appeal levels followed by external review with an independent medical reviewer. External review reverses about 40% of denials. Beyond appeals: discuss with your prescriber about manufacturer direct-pay programs (NovoCare $499/mo Wegovy, LillyDirect $349-549/mo Zepbound, orforglipron $149/mo), which don't require insurance approval. See our insurance coverage hub for plan-by-plan guidance.